<!DOCTYPE html>
<html lang="en">
<head>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title></title>
    <link rel="stylesheet" href="css/as.css" type="text/css" />
    <link rel="stylesheet" href="css/animate.css" type="text/css" />
    <script type="text/javascript" src="js/base.js"></script>
    <script type="text/javascript" src="js/Common.js"></script>
    <script type="text/javascript" charset="utf-8">

        //delay = 500;
        ANIMATION = [
        //'.chartbk, .title',
                 maskY('.blueline, .greenline'),
				fade('.greenline-labels, .blueline-labels'),

		   ];

    </script>
</head>
<body class="slide-3">
    <div id="content">
        <div class="collage">
        </div>
        <header>
ARTEMIS: Majority of patients in both arms achieved<br>viral load &lt;50 copies/mL at 96 weeks

</header>
        <div class="logo">
        </div>
        <section>

<article>
	<div class="chartwrap">
    	<div class="chartbk"></div>
        <div class="title">Percent of patients with HIV RNA &lt;50 copies/mL<br>at 96 week window (Weeks 90 through 102 ITT, TLOVR)<sup><span class="symbol"><strong>&dagger;</strong></span>3,4</sup></div>
    	<div class="blueline"></div>
        <div class="blueline-labels">74</div>
        <div class="greenline"></div>
        <div class="greenline-labels">78</div>
		<div class="disc"><span class="symbol">&dagger;</span>Statistical analysis not reported.</div>

    </div>

</article>

<aside>

<p class="bullet">In treatment-naïve patients, DRV/RTV was non-inferior to KALETRA<br>treatment for the primary endpoint at<br>Week 96.</p>
<p class="bullet">At week 96, virologic failure occurred<br>in 11% of DRV/RTV patients and 12%<br>of KALETRA patients.*&nbsp;<sup>4</sup></p>
<div class="disc" style="top: 312px; left:-20px; width: 300px; text-indent: -4px;">*Includes patients who discontinued prior to Week 96 for lack or loss of efficacy and patients who were <span class="symbol">&ge;</span>50 copies/mL in the 96 week window and patients who had a change in their background regimen that was not permitted by the protocol.</div>
</aside>

</section>
        <div class="buttonwrap">
            <button id="3" data-placement="top" onclick="makecall('PopupWithHeader',Array('as-03-popup-01','Study Design','<table width=\'900px\'><tr align=\'center\'><td class=\'reference\'>ARTEMIS Study Design<sup>2,3</sup></td></tr></table>','90','625','10','0','900','500','1','0','1','0'),this);">
                Study Design</button>
        </div>
        <footer>Please click buttons above for Indication and Important Safety Information about KALETRA.</footer>
    </div>
</body>
</html>